In this episode we chat about the sub-committees that provide advice to the main Pharmaceutical Benefits Advisory Committee. We are joined by Prof Richard Norman from the Economic Sub-Committee (ESC), and Prof Chris Etherton-Beer, Chair of the Drug Utilisation Sub-Committee (DUSC).

Richard is a health economist, so talks us through some of the health economic measures and considerations that go into ESC deciding whether to recommend that a medication should be subsidised through the Pharmaceutical Benefit Scheme (PBS).

Chris is a clinician at Royal Perth Hospital and pharmacology researcher at UWA. Chris talks us through some of the questions that around expected utilisation of drugs that are being considered for inclusion on the PBS. These include how many people would be likely to use the drug, and the health needs of populations that the particular drug may help.

You can about Richard here: https://staffportal.curtin.edu.au/staff/profile/view/richard-norman-6fd5494b/

about Chris here: https://research-repository.uwa.edu.au/en/persons/christopher-etherton-beer

For more information about the PBAC and its sub-committees: https://www.pbs.gov.au/info/industry/listing/participants/pbac

As always, if you want to get in touch with the podcast, you can contact us at: [email protected]
Instagram Twitter/X Bluesky @healthmeanswhat
FaceBook @MeaningofHealth
Or visit our website: www.meaningofhealth.com.au

Ver todos los episodios